Perhaps with objective but sensitive assessment procedures, COMT may prove to be a candidate genetic susceptibility marker of early cognitive changes associated with neurobiological disruptions that may be secondary or preliminary to AD-related neuropathology. This evidence concerns the gene COMT and Alzheimer disease.